Legal & General Group’s Evelo Biosciences, Inc. Common Stock EVLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-163
| Closed | -$11K | – | 3727 |
|
|
2022
Q1 | $11K | Hold |
163
| – | – | ﹤0.01% | 3392 |
|
|
2021
Q4 | $20K | Buy |
163
+2
| +1% | +$245 | ﹤0.01% | 3282 |
|
|
2021
Q3 | $23K | Hold |
161
| – | – | ﹤0.01% | 3235 |
|
|
2021
Q2 | $44K | Buy |
161
+35
| +28% | +$9.57K | ﹤0.01% | 2995 |
|
|
2021
Q1 | $27K | Buy |
126
+13
| +12% | +$2.79K | ﹤0.01% | 3029 |
|
|
2020
Q4 | $27K | Sell |
113
-21
| -16% | -$5.02K | ﹤0.01% | 2986 |
|
|
2020
Q3 | $14K | Buy |
134
+38
| +40% | +$3.97K | ﹤0.01% | 3110 |
|
|
2020
Q2 | $9K | Buy |
96
+20
| +26% | +$1.88K | ﹤0.01% | 3337 |
|
|
2020
Q1 | $6K | Sell |
76
-36
| -32% | -$2.84K | ﹤0.01% | 3250 |
|
|
2019
Q4 | $9K | Buy |
112
+5
| +5% | +$402 | ﹤0.01% | 3309 |
|
|
2019
Q3 | $13K | Hold |
107
| – | – | ﹤0.01% | 3236 |
|
|
2019
Q2 | $19K | Hold |
107
| – | – | ﹤0.01% | 3225 |
|
|
2019
Q1 | $17K | Hold |
107
| – | – | ﹤0.01% | 3146 |
|
|
2018
Q4 | $28K | Buy |
107
+67
| +168% | +$17.5K | ﹤0.01% | 2943 |
|
|
2018
Q3 | $10K | Hold |
40
| – | – | ﹤0.01% | 3325 |
|
|
2018
Q2 | $9K | Buy |
+40
| New | +$9K | ﹤0.01% | 3315 |
|